References
 
  1. Holm L-E, Wiklund KE, Lundell GE, Bergman NÅ, Bjelkengren G, Ericsson U-B, Cederquist ES, Lidberg M, Lindberg RS, Wicklund HV, Boice JD, Jr. Cancer risk in population examined with diagnostic doses of 131I. J Natl Cancer Inst 1989; 81: 302-306.


  2. Hall P, Boice JD, Jr., Berg G, Bjelkengren G, Ericsson U-B, Hallquist A, Lidberg M, Lundell G, Mattsson A, Tennvall J, Wiklund K, Holm L-E. Leukaemia incidence after iodine-131 exposure. Lancet 1992; 340: 1-4.


  3. International Commission on Radiological Protection. Radiation dose to patients from radiopharmaceuticals. Annals of the ICRP, Vol 18, Publication 53. Oxford: Pergamon Press, 1988.


  4. Hall P, Mattsson A, Boice JD, Jr. Thyroid cancer after diagnostic administration iodine-131. Radiat Res 1996; 145: 86-92.


  5. Hall P, Fürst CJ, Mattsson A, Holm L-E, Boice JD, Jr., Inskip PD. Thyroid nodularity after diagnostic administration of iodine-131. Radiat Res 1996; 146: 673-682.


  6. Shore RE, Hempelmann LH, Woodard ED. Carcinogenic effects of radiation on the human thyroid gland. In: Radiation Carcinogenesis. Eds. Upton AC, Albert RE, Burns FJ, Shore RE. New York: Elsevier, 1986: 293-309.


  7. United Nations Scientific Committee on the Effects of Atomic Radiation. Sources and effects of ionizing radiation. UNSCEAR 1994 Report to the General Assembly, with scientific annexes. New York: United Nations, 1994.


  8. Thompson DE, Mabuchi K, Ron E, Soda M, Tokunaga M, Ochikubo S, Sugimoto S, Ikeda T, Terasaki M, Izumi S, Preston DL. Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987. Radiat Res 1994; 137: 17-67.


  9. Wood JW, Tamagaki H, Neriish S, Sato T, Sheldon WF, Archer PG, Hamilton HB, Johnson KG. Thyroid carcinoma in atomic bomb survivors, Hiroshima and Nagasaki. Am J Epidemiol 1969; 89: 4-14.


  10. Shore RE. Issues and epidemiological evidence regarding radiation- induced thyroid cancer. Radiat Res 1992; 131: 98-111.


  11. Weiss HA, Darby SC, Doll R. Cancer mortality following X-ray treatment for ankylosing spondylitis. Int J Cancer 1994; 327-338.


  12. Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern LM, Schneider AB, Tucker MA, Boice JD, Jr. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 1995; 141: 259- 277.


  13. Ron E, Saftlas AF. Head and neck radiation carcinogenesis: epidemiologic evidence. Otolaryngol Head Neck Surg 1996; 115: 403-408.


  14. Inskip PD, Ekbom A, Galanti MR, Grimelius L, Boice JD, Jr. Medical diagnostic x rays and thyroid cancer. J Natl Cancer Inst 1995; 87: 1613- 1621.


  15. Shore RE, Hildreth N, Dvoretsky P, Endresen E, Moseson M, Pasternack B. Thyroid cancer among persons given x-ray treatment in infancy for an enlarged thymus gland. Am J Epidemiol 1993; 137: 1068-1080.


  16. Hamilton JG, Lawrence JH. Recent clinical developments in the therapeutic application of radio-phosphorus and radio-iodine. J Clin Invest 1942; 21: 624.


  17. Hertz S, Roberts A. Application of radioactive iodine in therapy of Graves' disease. J Clin Invest 1942; 21: 624.


  18. Saenger EL, Thoma GE, Tompkins EA. Incidence of leukemia following treatment of hyperthyroidism. Preliminary report of the Cooperative Thyrotoxicosis Therapy Follow-Up Study. JAMA 1968; 205: 855-862.


  19. Dobyns BM, Sheline GE, Workman JB, Tompkins EA, McConahey WM, Becker DV. Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: a report of the Cooperative Thyrotoxicosis Therapy Follow-up Study. J Clin Endocrinol Metab 1974; 38: 976-998.


  20. Hoffman DA. Late effects of I-131 therapy in the United States. In Radiation carcinogenesis: epidemiology and biological significance. Eds. Boice JD, Jr, Fraumeni JF, Jr. New York: Raven Press, 1984: 273-280.


  21. Holm L-E, Hall P, Wiklund K, Lundell G, Berg G, Bjelkengren G, Cederquist E, Ericsson U-B, Hallquist A, Larsson L-G, Lidberg M, Lindberg S, Tennvall J, Wicklund H, Boice JD, Jr. Cancer risk after iodine-131 therapy for hyperthyroidism. J Natl Cancer Inst 1991; 83: 1072-1077.


  22. Hall P, Lundell G, Holm L-E. Mortality in patients treated for hyperthyroidism with iodine-131. Acta Endocrinol 1993; 128: 230-234.


  23. Bartalena L, Martino E, Marcocci C, Bogazzi F, Panicucci M, Velluzzi F, Loviselli A, Pinchera A. More on smoking habits and Graves' ophtalmopathy. J Endocrinol Invest 1989; 12: 733-737.


  24. Ericsson U-E, Lindgärde F. Effects of cigarette smoking on thyroid function and the prevalence of goitre, thyrotoxicosis and autoimmune thyroiditis. J Intern Med 1991; 229: 67-71.


  25. Tubiana M, Schlumberger M, Rougier P, Laplanche A, Benhamou E, Gardet P, Caillou B, Travagli J-P, Permentier C. Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 1985; 55: 794- 804.


  26. Gilliland FD, Hunt WC, Morris DM, Key CR. Prognostic factors for thyroid carcinoma. A popultion-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program. Cancer 1997; 79: 564- 573.